Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management

References

• Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–698.
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. Obstructive sleep apnea, adult. International Classification of Sleep Disorders. 3rd ed. ed. Darien, IL: American Academy of Sleep Medicine; 2014. p. 53–62.
   Google Scholar
• Bailly S, Destors M, Grillet Y, et al. Obstructive sleep apnea: a cluster analysis at time of diagnosis. PLoS One. 2016;11(6):e0157318.
   PubMed Web of Science ®Google Scholar
• Koutsourelakis I, Perraki E, Economou NT, et al. Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients. Eur Respir J. 2009;34(3):687–693. .
   PubMed Web of Science ®Google Scholar
• Kapur VK, Baldwin CM, Resnick HE, et al. Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep. 2005;28(4):472–477.
   PubMed Web of Science ®Google Scholar
• Smith S, Rossdale J, Serry Y, et al. Multiple dimensions of excessive daytime sleepiness. J Thorac Dis. 2018;10(Suppl 1):S170–s176.
   PubMed Web of Science ®Google Scholar
• Keenan BT, Kim J, Singh B, et al. Recognizable clinical subtypes of obstructive sleep apnea across international sleep centers: a cluster analysis. Sleep. 2018;41(3):3.
   Web of Science ®Google Scholar
• Lal C, Weaver TE, Bae CJ, et al. Excessive daytime sleepiness in obstructive sleep apnea: mechanisms and clinical management. Ann Am Thorac Soc. 2021;18(5):757–768.
   PubMed Web of Science ®Google Scholar
• Macey PM, Woo MA, Kumar R, et al. Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PLoS One. 2010;5(4):e10211.
   PubMed Web of Science ®Google Scholar
• Gabryelska A, Białasiewicz P. Association between excessive daytime sleepiness, REM phenotype and severity of obstructive sleep apnea. Sci Rep. 2020;10(1):34.
   PubMed Web of Science ®Google Scholar
• Kendzerska TB, Smith PM, Brignardello-Petersen R, et al. Evaluation of the measurement properties of the Epworth Sleepiness Scale: a systematic review. Sleep Med Rev. 2014;18(4):321–331.
   PubMed Web of Science ®Google Scholar
• Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2019;15(2):335–343.
   PubMed Web of Science ®Google Scholar
• Epstein LJ, Kristo D, Strollo PJ Jr., et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–276.
   PubMed Web of Science ®Google Scholar
• Gasa M, Tamisier R, Launois SH, et al. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure. J Sleep Res. 2013;22(4):389–397.
   PubMed Web of Science ®Google Scholar
• Pepin JL, Viot-Blanc V, Escourrou P, et al. Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J. 2009;33(5):1062–1067.
   PubMed Web of Science ®Google Scholar
• Antic NA, Catcheside P, Buchan C, Antic NA, Catcheside P, Buchan C, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep. 2011;34(1):111–119.
   PubMed Web of Science ®Google Scholar
• Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30(6):711–719.
   PubMed Web of Science ®Google Scholar
• Budhiraja R, Kushida CA, Nichols DA, et al. Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy. Eur Respir J. 2017;50(5):5.
   Web of Science ®Google Scholar
• Stepnowsky C, Sarmiento KF, Bujanover S, et al. Comorbidities, health-related quality of life, and work productivity among people with obstructive sleep apnea with excessive sleepiness: findings from the 2016 US National Health and Wellness Survey. J Clin Sleep Med. 2019;15(2):235–243.
   PubMed Web of Science ®Google Scholar
• Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest. 2012;141(6):1601–1610.
   PubMed Web of Science ®Google Scholar
• Werli KS, Otuyama LJ, Bertolucci PH, et al. Neurocognitive function in patients with residual excessive sleepiness from obstructive sleep apnea: a prospective, controlled study. Sleep Med. 2016;26:6–11.
   PubMed Web of Science ®Google Scholar
• Tramonti F, Maestri M, Carnicelli L, et al. Relationship quality of persons with obstructive sleep apnoea syndrome. Psychol Health Med. 2017;22(8):896–901.
   PubMed Web of Science ®Google Scholar
• Mulgrew AT, Ryan CF, Fleetham JA, et al. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med. 2007;9(1):42–53.
   PubMed Web of Science ®Google Scholar
• Tregear S, Reston J, Schoelles K, et al. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. J Clin Sleep Med. 2009;5(6):573–581.
   PubMed Web of Science ®Google Scholar
• Garbarino S, Guglielmi O, Sanna A, et al. Risk of occupational accidents in workers with obstructive sleep apnea: systematic review and meta-analysis. Sleep. 2016;39(6):1211–1218.
   PubMed Web of Science ®Google Scholar
• Mazza S, Pépin JL, Naëgelé B, et al. Driving ability in sleep apnoea patients before and after CPAP treatment: evaluation on a road safety platform. Eur Respir J. 2006;28(5):1020–1028.
   PubMed Web of Science ®Google Scholar
• Philip P, Bailly S, Benmerad M, et al. Self-reported sleepiness and not the apnoea hypopnoea index is the best predictor of sleepiness-related accidents in obstructive sleep apnoea. Sci Rep. 2020;10(1):16267.
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Ellenbogen JM, Bianchi MT, et al. Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study. BMC Med. 2018;16(1):44. .
   PubMed Web of Science ®Google Scholar
• Jennum P, Castro JPC, Mettam S, et al. Socioeconomic and humanistic burden of illness of excessive daytime sleepiness severity associated with obstructive sleep apnoea in the European Union 5. Sleep Med. 2021; 84:46-55.
   Google Scholar
• Won CH, Bogan RK, Doghramji K, et al. Assessing communication between physicians and patients with excessive daytime sleepiness associated with treated obstructive sleep apnea: insights from an ethnographic study of in-office visits [abstract]. Am J Respir Crit Care Med. 2019;199:A1390.
   Web of Science ®Google Scholar
• Pépin JL, Tamisier R, Hwang D, et al. Does remote monitoring change OSA management and CPAP adherence? Respirology. 2017;22(8):1508–1517.
   PubMed Web of Science ®Google Scholar
• He K, Kapur VK. Sleep-disordered breathing and excessive daytime sleepiness. Sleep Med Clin. 2017;12(3):369–382.
   PubMed Web of Science ®Google Scholar
• Javaheri S, Javaheri S. Update on persistent excessive daytime sleepiness in OSA [Review]. Chest. 2020;158(2):776–786.
   PubMed Web of Science ®Google Scholar
• Chervin RD. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest. 2000;118(2):372–379.
   PubMed Web of Science ®Google Scholar
• Vernet C, Redolfi S, Attali V, et al. Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms. Eur Respir J. 2011;38(1):98–105.
   PubMed Web of Science ®Google Scholar
• Arand D, Bonnet M, Hurwitz T, et al. The clinical use of the MSLT and MWT. Sleep. 2005;28(1):123–144.
   PubMed Web of Science ®Google Scholar
• Thomann J, Baumann CR, Landolt HP, et al. Psychomotor vigilance task demonstrates impaired vigilance in disorders with excessive daytime sleepiness. J Clin Sleep Med. 2014;10(9):1019–1024.
   PubMed Web of Science ®Google Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540–545.
   PubMed Web of Science ®Google Scholar
• Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20(10):844–849.
   PubMed Web of Science ®Google Scholar
• Lapin BR, Bena JF, Walia HK, et al. The Epworth Sleepiness Scale: validation of One-Dimensional Factor Structure in a Large Clinical Sample. J Clin Sleep Med. 2018;14(8):1293–1301.
   PubMed Web of Science ®Google Scholar
• Rosenberg R, Babson K, Menno D, et al. Epworth Sleepiness Scale Test-Retest Reliability Analysis In Solriamfetol Studies [abstract]. Sleep. 2020;43(Suppl 1):A285–A286.
   Google Scholar
• Taylor E, Zeng I, O’Dochartaigh C. The reliability of the Epworth Sleepiness Score in a sleep clinic population. J Sleep Res. 2019;28(2):e12687.
   PubMed Web of Science ®Google Scholar
• Campbell AJ, Neill AM, Scott DAR. Clinical reproducibility of the Epworth Sleepiness Scale for patients with suspected sleep apnea. J Clin Sleep Med. 2018;14(5):791–795.
   PubMed Web of Science ®Google Scholar
• Nguyen ATD, Baltzan MA, Small D, Nguyen AT, Baltzan MA, Small D, et al. Clinical reproducibility of the Epworth Sleepiness Scale. J Clin Sleep Med. 2006;2(2):170–174.
   PubMed Web of Science ®Google Scholar
• Ayeni A, Beghal GS, Pengo MF, et al. Self-reported sleepiness in the context of fitness-to-drive. Sleep Breath. 2019;23(4):1227–1232.
   PubMed Web of Science ®Google Scholar
• Bonzelaar LB, Salapatas AM, Yang J, et al. Validity of the epworth sleepiness scale as a screening tool for obstructive sleep apnea. Laryngoscope. 2017;127(2):525–531.
   PubMed Web of Science ®Google Scholar
• Hunasikatti M. Low repeatability of the Epworth Sleepiness Scale and the need to redefine the minimal clinically important difference. J Clin Sleep Med. 2020;16(10):1827.
   PubMed Web of Science ®Google Scholar
• Grewe FA, Roeder M, Bradicich M, et al. Low repeatability of Epworth Sleepiness Scale after short intervals in a sleep clinic population. J Clin Sleep Med. 2020;16(5):757–764.
   PubMed Web of Science ®Google Scholar
• Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10(4):431–436.
   PubMed Web of Science ®Google Scholar
• Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. 1990;52(1–2):29–37.
   PubMed Web of Science ®Google Scholar
• Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45(1):43.
   PubMed Web of Science ®Google Scholar
• Weaver TE, Sawyer AM. Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. Indian J Med Res. 2010;131:245–258.
   PubMed Web of Science ®Google Scholar
• Schwab RJ, Badr SM, Epstein LJ, et al. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med. 2013;188(5):613–620.
   PubMed Web of Science ®Google Scholar
• Pengo MF, Czaban M, Berry MP, et al. The effect of positive and negative message framing on short term continuous positive airway pressure compliance in patients with obstructive sleep apnea. J Thorac Dis. 2018;10(Suppl 1):S160–S169.
   PubMed Web of Science ®Google Scholar
• Weaver TE. Novel Aspects of CPAP Treatment and Interventions to Improve CPAP Adherence. J Clin Med. 2019;8(12):12.
   Web of Science ®Google Scholar
• Neu D, Balkissou AD, Mairesse O, et al. Complex sleep apnea at auto-titrating CPAP initiation: prevalence, significance and predictive factors. Clin Respir J. 2017;11(2):200–209.
   PubMed Web of Science ®Google Scholar
• Nigam G, Riaz M, Chang ET, et al. Natural history of treatment-emergent central sleep apnea on positive airway pressure: a systematic review. Ann Thorac Med. 2018;13(2):86–91.
   PubMed Web of Science ®Google Scholar
• Liu D, Armitstead J, Benjafield A, et al. Trajectories of Emergent Central Sleep Apnea During CPAP Therapy. Chest. 2017;152(4):751–760.
   PubMed Web of Science ®Google Scholar
• Pépin JL, Woehrle H, Liu D, et al. Adherence to Positive Airway Therapy After Switching From CPAP to ASV: a Big Data Analysis. J Clin Sleep Med. 2018;14(1):57–63.
   PubMed Web of Science ®Google Scholar
• Sleep and sleep disorders data and statistics: centers for Disease Control and Prevention; 2017 [2020 Oct 16]. Available from: https://www.cdc.gov/sleep/data_statistics.html.
   Google Scholar
• Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38(6):843–844.
   PubMed Web of Science ®Google Scholar
• Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394.
   PubMed Web of Science ®Google Scholar
• Lowden A, Holmbäck U, Akerstedt T, et al. Performance and sleepiness during a 24 h wake in constant conditions are affected by diet. Biol Psychol. 2004;65(3):251–263.
   PubMed Web of Science ®Google Scholar
• Panossian LA, Veasey SC. Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea--a review. Sleep. 2012;35(5):605–615.
   PubMed Web of Science ®Google Scholar
• Lins-Filho OL, Pedrosa RP, Gomes JML, et al. Effect of exercise training on subjective parameters in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med. 2020;69:1–7.
   PubMed Web of Science ®Google Scholar
• Pagel JF. Excessive daytime sleepiness. Am Fam Physician. 2009;79(5):391–396.
   PubMed Web of Science ®Google Scholar
• Pagel JF. Drug-Induced Hypersomnolence. Sleep Med Clin. 2017;12(3):383–393.
   PubMed Web of Science ®Google Scholar
• Ejaz SM, Khawaja IS, Bhatia S, et al. Obstructive sleep apnea and depression: a review. Innov Clin Neurosci. 2011;8(8):17–25.
   PubMedGoogle Scholar
• Luyster FS, Buysse DJ, Strollo PJ Jr. Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research. J Clin Sleep Med. 2010;6(2):196–204.
   PubMed Web of Science ®Google Scholar
• Ong JC, Crawford MR, Wallace DM. Sleep apnea and insomnia: emerging evidence for effective clinical management. Chest. 2021;159(5):2020–2028.
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
   Google Scholar
• Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the Multiple Sleep Latency Test and the Maintenance of Wakefulness Test. Sleep. 2005;28(1):113–121.
   PubMed Web of Science ®Google Scholar
• Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res. 1997;6(2):142–145.
   PubMed Web of Science ®Google Scholar
• Dinges DF, Powell JW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput. 1985;17(6):652–655.
   Google Scholar
• Goldstein C. Current GC. Future Roles of Consumer Sleep Technologies in Sleep Medicine. Sleep Med Clin. 2020;15(3):391–408.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang J, Lei F, et al. Self-evaluated and close relative-evaluated Epworth Sleepiness Scale vs multiple sleep latency test in patients with obstructive sleep apnea. J Clin Sleep Med. 2014;10(2):171–176.
   PubMed Web of Science ®Google Scholar
• Li Y, Vgontzas A, Kritikou I, et al. Psychomotor Vigilance Test and Its Association With Daytime Sleepiness and Inflammation in Sleep Apnea: clinical Implications. J Clin Sleep Med. 2017;13(9):1049–1056.
   PubMed Web of Science ®Google Scholar
• Provigil [package insert]. North Wales, PA: Teva Pharmaceuticals; 2018 November. 2018.
   Google Scholar
• Nuvigil [package insert]. North Wales, PA: Teva Pharmaceuticals; 2018 November. 2018.
   Google Scholar
• Sunosi™ (solriamfetol) tablets Prescribing Information. June 2019. Palo Alto, CA: Jazz Pharmaceuticals, Inc; 2019.
   Google Scholar
• Wakix [package insert]. Plymouth Meeting, PA: Harmony Biosciences; 2020 October. 2020.
   Google Scholar
• Ritalin [package insert]. 2019 November. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2019.
   Google Scholar
• Concerta [package insert]. Titusville, NJ: Janssen Pharmaceuticals; 2017 January. 2017.
   Google Scholar
• Adderall [package insert]. Horsham, PA: Teva Pharmaceuticals; 2017 January. 2017.
   Google Scholar
• Dextroamphetamine sulfate [package insert]. North Wales, PA: Teva Pharmaceuticals; 2016 September. 2016.
   Google Scholar
• Dauvilliers Y, Verbraecken J, Partinen M, et al. Pitolisant for daytime sleepiness in obstructive sleep apnea patients refusing CPAP: a randomized trial. Am J Respir Crit Care Med. 2020;201(9):1135–1145.
   PubMed Web of Science ®Google Scholar
• Pack AI, Black JE, Schwartz JR, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;164(9):1675–1681.
   PubMed Web of Science ®Google Scholar
• Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28(4):464–471.
   PubMed Web of Science ®Google Scholar
• Hirshkowitz M, Black JE, Wesnes K, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med. 2007;101(3):616–627.
   PubMed Web of Science ®Google Scholar
• Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther. 2006;28(5):689–706.
   PubMed Web of Science ®Google Scholar
• Hirshkowitz M, Black J. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study. CNS Drugs. 2007;21(5):407–416.
   PubMed Web of Science ®Google Scholar
• Black JE, Hull SG, Tiller J, et al. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study. J Clin Sleep Med. 2010;6(5):458–466.
   PubMed Web of Science ®Google Scholar
• Chapman JL, Vakulin A, Hedner J, et al. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis. Eur Respir J. 2016;47(5):1420–1428.
   PubMed Web of Science ®Google Scholar
• Chapman JL, Serinel Y, Marshall NS, et al. Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: causes and Management. Sleep Med Clin. 2016;11(3):353–363.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Modafinil - Article 31 referral - Annex I, II, III, IV London. United Kingdom: European Medicines Agency; 2011 2019 Jan 24. Available from https://www.ema.europa.eu/documents/referral/modafinil-article-31-referral-annex-i-ii-iii-iv_en.pdf.
   Google Scholar
• Sukhal S, Khalid M, Tulaimat A. Effect of wakefulness-promoting agents on sleepiness in patients with sleep apnea treated with CPAP: a meta-analysis. J Clin Sleep Med. 2015;11(10):1179–1186.
   PubMed Web of Science ®Google Scholar
• Health Canada. ALERTEC (modafinil) and the risk of congenital anomalies: health Canada; 2019 [2020 Jan 8]. Available from: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70201a-eng.php.
   Google Scholar
• Sunosi™ (solriamfetol) tablets Summary of Product Characteristics. January 2020. Dublin, Ireland: Jazz Pharmaceuticals Ireland Ltd; 2020.
   Google Scholar
• Schweitzer PK, Rosenberg R, Zammit GK, et al. Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3): a randomized controlled trial. Am J Respir Crit Care Med. 2019;199(11):1421–1431.
   PubMed Web of Science ®Google Scholar
• Strollo PJ Jr., Hedner J, Collop N, et al. Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study. Chest. 2019;155(2):364–374.
   PubMed Web of Science ®Google Scholar
• Malhotra A, Shapiro C, Pepin JL, et al. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea. Sleep. 2020;43(2):zsz220.
   PubMed Web of Science ®Google Scholar
• Wakix (pitolisant) Summary of Product Characteristics.  January 2019. Paris, France: Bioprojet Pharm; 2019.
   Google Scholar
• Pépin JL, Georgiev O, Tiholov R, et al. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial. Chest. 2021;159(4):1598–1609.
   PubMed Web of Science ®Google Scholar
• Rosenberg R, Baladi M, Menno D, et al. Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a post-hoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnoea [abstract]. Sleep Med. 2019;64(11):S325.
   Google Scholar
• Scrima L, Emsellem HA, Becker PM, et al. Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110. Sleep Med. 2017;38:108–112.
   PubMed Web of Science ®Google Scholar
• Lammers GJ, Bogan R, Schweitzer PK, et al. Thresholds for clinically meaningful changes on the Epworth Sleepiness Scale and Maintenance of Wakefulness Test sleep latency [abstract]. Sleep Med. 2019;64(suppl 1):S210.
   Google Scholar
• Patel S, Kon SSC, Nolan CM, et al. The Epworth Sleepiness Scale: minimum clinically important difference in obstructive sleep apnea. Am J Respir Crit Care Med. 2018;197(7):961–963.
   PubMed Web of Science ®Google Scholar
• Rosenberg R, Schweitzer PK, Malhotra A, et al. Incidence and duration of common adverse events in a solriamfetol (JZP-110) phase 3 study for treatment of excessive daytime sleepiness in obstructive sleep apnea [abstract 0569]. Sleep. 2019;42(suppl 1):A226–A227.
   Google Scholar
• Schweitzer PK, Strohl KP, Mayer G, et al. Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy. J Clin Sleep Med. 2021;17(4):659–668.
   PubMed Web of Science ®Google Scholar